ERLOMAPS-150

What is ERLOMAPS-150?

ERLOMAPS-150 is a prescription medication containing Erlotinib 150 mg as its active ingredient. Erlotinib is a tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR), helping to slow the growth and spread of certain cancer cells.

---

What is the Use of ERLOMAPS-150?

ERLOMAPS-150 is primarily used to:

• Treat non-small cell lung cancer (NSCLC) with EGFR mutations.

• Manage pancreatic cancer in combination with chemotherapy.

• Provide a targeted therapy option for patients with EGFR-positive cancers.

---

Benefits of ERLOMAPS-150

• Slows tumor growth by inhibiting EGFR signaling in cancer cells.

• Can be used in combination with chemotherapy for enhanced treatment efficacy.

• Offers a targeted therapy approach, reducing the impact on healthy cells compared to conventional chemotherapy.

---

Side Effects of ERLOMAPS-150

Common side effects include:

• Skin rash or acne-like eruptions

• Diarrhea

• Nausea or loss of appetite

• Fatigue

Serious but rare side effects may include:

• Severe liver problems

• Interstitial lung disease

• Severe allergic reactions or eye disorders

Regular monitoring of liver function and clinical symptoms is recommended during treatment.

1. What is ERLOMAPS-150 used for?

It is used to treat EGFR-positive non-small cell lung cancer (NSCLC) and pancreatic cancer in combination with chemotherapy.

2. What is the active ingredient in ERLOMAPS-150?

The active ingredient is Erlotinib 150 mg, a tyrosine kinase inhibitor.

3. How does ERLOMAPS- 150 work?

It blocks EGFR signaling in cancer cells, slowing or stopping tumor growth.

4. How should ERLOMAPS- 150 be taken?

Take one tablet daily on an empty stomach, at least 1 hour before or 2 hours after food, or as prescribed by your doctor.

5. Can ERLOMAPS- 150 be used with other medications?

Yes, but inform your doctor about all medications and supplements, as some may interact with Erlotinib.

6. What are common side effects?

Common side effects include skin rash, diarrhea, nausea, loss of appetite, and fatigue.

7. What are serious side effects?

Serious effects may include liver problems, interstitial lung disease, eye disorders, or severe allergic reactions. Seek immediate medical attention if these occur.

8. Who should avoid ERLOMAPS- 150?

Patients with allergies to Erlotinib, liver disease, or lung disorders should avoid it unless prescribed by a doctor.

9. Can pregnant or breastfeeding women use ERLOMAPS- 150?

Its safety in pregnancy and breastfeeding is not established. It should only be used if clearly indicated by a healthcare professional.

10. How long does it take to work?

The response varies; tumor growth may slow over several weeks, depending on the type and stage of cancer.

11. Can I drink alcohol while taking ERLOMAPS- 150?

Alcohol may worsen liver function and side effects, so it is best to avoid or limit alcohol.

12. Is regular monitoring required?

Yes. Regular liver function tests, lung assessments, and clinical check-ups are recommended during treatment.

13. What should I do if I miss a dose?

Take it as soon as you remember, unless it’s almost time for the next dose. Do not double the dose.

14. Can ERLOMAPS- 150 cure cancer?

No. ERLOMAPS-150 slows tumor growth and improves outcomes, but it is not a definitive cure.

15. How should ERLOMAPS- 150 be stored?

Store in a cool, dry place away from sunlight and moisture, out of reach of children.